This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 13Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2124 | 2-pyrocatechuic acid | Metabolites | Mice | Upregulated in AFLD | Potential Predictive * | Serum biochemical analysis, antioxidant enzyme activity analysis, and histopathological evaluation revealed that GEO and citral exhibited hepatoprotective activity against AFLD. Metabolites in serum samples were profiled | Serum | 24171385 | |
2232 | CCAT2 | LncRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.05 | Tissue | 27347113 |
2234 | CCAT2 | LncRNA | Human | Upregulated in HCC | Prognostic | HCC v/s Normal; associated with poor survival in HCC patients | p < 0.01 | Tissue | 28280353 |
2238 | CCAT1 | LncRNA | Human | Upregulated in HCC | Prognostic | HCC v/s Normal; correlated with tumor size, microvascular invasion and poor prognosis | p < 0.001 | Tissue | 25884472 |
2268 | LIMK1, CENPE, FZD2, ENO2, ITGA9, COPA, KIAA0660, GTF2H1, VPS41, RGS20, MATK, STOML1, BASP1, EPB42, ALDH3B2, MEL, CAT56, RAB3A, PSCD3, PLD2, ADCYAP1R1, ALDH3B1, RHD, CSF3R, KIAA0063, KIAA0296, LRP6, ENO3, CTRB1, YES1, IncytePD:1404153, GYS1, MDFI, GABRE, IncytePD:2685601, CD3Z, DTYMK, SPTBN2, IncyteP | RNAs | Human | Upregulated in PT than PN (with 3 fold change) | Diagnostic | Metastatic HCC v/s Primary HCC | p < 0.01 | Tissue | 12640447 |
2470 | HSP27, Enoyl-CoA hydratase, Tubulin β chain, Galactose kinase, Ubiquinol-cytochrome C reductase complex core protein I, Annexin V, P-PST, Ribosome binding protein, Fumarylacetoacetase, ALDH, Catalase, | Protein | Human | Differentially expressed (P-PST, Ribosome binding protein, Fumarylacetoacetase, Catalase and ALDH are Downregulated and rest 6 are Upregulated) in HCC tumor v/s non-tumorous | Diagnostic | Both HBV- and HCV associated HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
2471 | Protein disulfide isomerase ER-60, PRBP, Tropomyosin 3, ATP synthase, Dihydropipoamide dehydrogenase, FABP, Cathepsin B1, | Protein | Human | Differentially expressed (FABP, Cathepsin B1 are Downregulated and rest 5 are Upregulated) in HCC tumor v/s non-tumorous | Diagnostic | both (HBV and HCV) negative HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
2495 | Cathepsin D | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 3.5 +/- 3.3) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
2497 | Catechol O-methyltransferase | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 3.2 +/- 3.8) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
2502 | CAPG, OCC-1, EED, RPLP0, RPLP0P2, AP1S2, RRAGD, PFDN4, CCDC104, C7orf28B, PSIP1, LPCAT1, FSCN3, RAB24, ZNF446, SEC11B, ZNF586, SCNM1, SF3A1, RUFY1, TRIM55, GOLGA4, GPATCH4, THOP1, TUBB2C, PHLDB3, FAM104A, FASTK, EIF2AK4, ZFP41, PRKRIP1, DSTN, PHIP, NUCKS1, TNRC8, CCDC132, EPRS, HIST1H4C, CDCA8, | RNAs | Human | Upregulated in HCV related HCC than HCV related non-HCC (With 3-fold change) | Diagnostic | HCV related HCC v/s HCV related non-HCC | p < 0.01 | Tissue | 19821982 |
2505 | Lactate dehydrogenase, aldehyde oxidase, nucleoside diphosphate kinase, alpha 1 catenin, beta catenin, transforming protein rho B, IgG, IgGK, IgG3, IgG1, IgG1K, IgA1, IgHA, IgG1-Fc, Collagen - alpha 1 subunit, c-jun N-terminal kinase 2, ADP/ATP carrier protein, Progression receptor associated protei | RNAs | Human | Diffrenetially expressed in cirrhotic v/s non-cirrhotic | Diagnostic | cirrhotic v/s non-cirrhotic | p < 0.01 | Tissue | 11973655 |
2553 | Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6- | Protein | Human | Downregulated in poorly-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
2581 | Cystatin C, Prolylcarboxypeptidase (angiotensinase C), Lysyl-tRNA synthetase, Voltage-dependent anion channel 3, Protective protein for beta-galactosidase (cathepsin A), Interferon gamma-inducible protein 30, Signal sequence receptor delta, Thioredoxin-related transmembrane protein, Cathepsin D, Ras | RNAs | Human | Upregulated in L1 than L0 (with Fisher ratio more than 8.9) | Prognostic | non-tumorous livers L1 (with HCV infection) v/s and L0 (without HCV infection) ; associated with invasion or metastsis | P = 0.001 | Tissue | 15710396 |